IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis

Background Based on their capacity to suppress immune responses, multipotent mesenchymal stromal cells (MSC) are intensively studied for various clinical applications. Although it has been shown in vitro that the immunomodulatory effect of MSCs mainly occurs through the secretion of soluble mediators, the mechanism is still not completely understood. The aim of the present study was to better understand the mechanisms underlying the suppressive effect of MSCs in vivo, using cells isolated from mice deficient in the production of inducible nitric oxide synthase (iNOS) or interleukin (IL)-6 in the murine model of collagen-induced arthritis. Principal Findings In the present study, we show that primary murine MSCs from various strains of mice or isolated from mice deficient for iNOS or IL-6 exhibit different immunosuppressive potential. The immunomodulatory function of MSCs was mainly attributed to IL-6-dependent secretion of prostaglandin E2 (PGE2) with a minor role for NO. To address the role of these molecules in vivo, we used the collagen-induced arthritis as an experimental model of immune-mediated disorder. MSCs effectively inhibited collagen-induced inflammation during a narrow therapeutic window. In contrast to wild type MSCs, IL-6-deficient MSCs and to a lesser extent iNOS-deficient MSCs were not able to reduce the clinical signs of arthritis. Finally, we show that, independently of NO or IL-6 secretion or Treg cell induction, MSCs modulate the host response by inducing a switch to a Th2 immune response. Significance Our data indicate that MSCs mediate their immunosuppressive effect via two modes of action: locally, they reduce inflammation through the secretion of anti-proliferative mediators, such as NO and mainly PGE2, and systemically they switch the host response from a Th1/Th17 towards a Th2 immune profile.

[1]  F. Djouad,et al.  Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases , 2009, Nature Reviews Rheumatology.

[2]  R. Willemze,et al.  Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells1 , 2006, The Journal of Immunology.

[3]  N. Rouas-Freiss,et al.  Human Leukocyte Antigen‐G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells , 2008, Stem cells.

[4]  F. Djouad,et al.  Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[5]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell Stem Cell.

[6]  R. Cancedda,et al.  Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. , 2007, Arthritis and rheumatism.

[7]  C. Gabay,et al.  Remission of collagen‐induced arthritis is associated with high levels of transforming growth factor‐β expression in the joint , 2006, Clinical and experimental immunology.

[8]  H. Nagai,et al.  Interleukin-1B Induces Interleukin-6 Production through the Production of Prostaglandin E2 in Human Osteoblasts, MG-63 Cells , 1999 .

[9]  Q. Myrvik,et al.  Splenic PGE2‐releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat‐killed BCG , 2005, Journal of leukocyte biology.

[10]  O. Danos,et al.  Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. , 2002, Human gene therapy.

[11]  F. Djouad,et al.  Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications , 2010, Stem Cell Research & Therapy.

[12]  S. Poole,et al.  Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[13]  Manuel A. González,et al.  Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis , 2009, Annals of the rheumatic diseases.

[14]  R. Willemze,et al.  Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. , 2006, Blood.

[15]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer – cell proliferation , cytotoxicity , and cytokine production : role of indoleamine 2 , 3-dioxygenase and prostaglandin E 2 , 2008 .

[16]  T. Moilanen,et al.  Leptin Enhances Synthesis of Proinflammatory Mediators in Human Osteoarthritic Cartilage—Mediator Role of NO in Leptin-Induced PGE2, IL-6, and IL-8 Production , 2009, Mediators of inflammation.

[17]  C. Jorgensen,et al.  Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. , 1998, Journal of immunology.

[18]  N. Mahmud,et al.  Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. , 2001, Human gene therapy.

[19]  Tomoki Ito,et al.  Prostaglandin E2 is a negative regulator on human plasmacytoid dendritic cells , 2006, Immunology.

[20]  Danièle Noël,et al.  Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. , 2009, Trends in biotechnology.

[21]  J. Rossignol,et al.  A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. , 2007, Blood.

[22]  W. Murphy,et al.  IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. , 1997, Journal of immunology.

[23]  D. Wink,et al.  A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. , 2001, Nitric oxide : biology and chemistry.

[24]  U. Hadding,et al.  Interleukin-1 Inhibits Gamma Interferon-Induced Bacteriostasis in Human Uroepithelial Cells , 1999, Infection and Immunity.

[25]  Darwin J. Prockop,et al.  Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice , 2006, Proceedings of the National Academy of Sciences.

[26]  T. Huizinga,et al.  Immature Dendritic Cells Suppress Collagen-Induced Arthritis by In Vivo Expansion of CD49b+ Regulatory T Cells1 , 2006, The Journal of Immunology.

[27]  Ruth S. Waterman,et al.  A New Mesenchymal Stem Cell (MSC) Paradigm: Polarization into a Pro-Inflammatory MSC1 or an Immunosuppressive MSC2 Phenotype , 2010, PloS one.

[28]  J. Frelinger,et al.  Francisella tularensis-Infected Macrophages Release Prostaglandin E2 that Blocks T Cell Proliferation and Promotes a Th2-Like Response1 , 2007, The Journal of Immunology.

[29]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[30]  N. Zvaifler,et al.  Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. , 2002, Arthritis and rheumatism.

[31]  Q. Han,et al.  Flk‐1+ mesenchymal stem cells aggravate collagen‐induced arthritis by up‐regulating interleukin‐6 , 2010, Clinical and experimental immunology.

[32]  S. Setty,et al.  IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease , 2008, European journal of immunology.

[33]  R. Toes,et al.  Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. , 2005, Arthritis and rheumatism.

[34]  L. Moretta,et al.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. , 2009, Blood.

[35]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[36]  M. Yarmush,et al.  Bone Marrow‐Derived Mesenchymal Stem Cells Ameliorate Autoimmune Enteropathy Independently of Regulatory T Cells , 2008, Stem cells.

[37]  A. Poggi,et al.  Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells. , 2008, Human immunology.

[38]  Manuel A. González,et al.  Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. , 2009, Arthritis and rheumatism.

[39]  F. Canovas,et al.  Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells , 2005, Arthritis research & therapy.

[40]  A. Poggi,et al.  Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. , 2007, Haematologica.

[41]  E. Bollen,et al.  Interaction of indomethacin with cytokine production in whole blood. Potential mechanism for a brain-protective effect , 2000, Experimental Gerontology.

[42]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.

[43]  David Klatzmann,et al.  Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice1 , 2006, The Journal of Immunology.

[44]  George Kollias,et al.  Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases , 2008, The Journal of experimental medicine.

[45]  F. Djouad,et al.  Multipotent mesenchymal stromal cells and immune tolerance , 2007, Leukemia & lymphoma.

[46]  G. Mancardi,et al.  Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. , 2005, Blood.

[47]  C. Cho,et al.  Mesenchymal stem cells overexpressing interleukin‐10 attenuate collagen‐induced arthritis in mice , 2008, Clinical and experimental immunology.

[48]  Anoop P. Patel,et al.  Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. , 2006, Blood.

[49]  H. Nagai,et al.  Interleukin-1beta induces interleukin-6 production through the production of prostaglandin E(2) in human osteoblasts, MG-63 cells. , 1999, Journal of biochemistry.

[50]  H. Kelchtermans,et al.  Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis , 2010, Arthritis research & therapy.

[51]  Kazuya Sato,et al.  Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. , 2007, Blood.

[52]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.